DV
Dividend Vision

OGN — Organon & Co.

Organon & Co. (OGN)

OGN pays a 0.59% distribution rate, quarterly. Its Distribution Safety Score™ is 8 (High risk), giving a Safety-Adjusted Yield of 0.05%. Total return is -49.4% over the past 5.3 years, 149.5 points behind SPY at 100.1%. Its deepest 1-year drawdown was 48.0%.

Organon & Co. is a pharmaceutical company that develops and delivers women's health solutions through prescription therapies and medical devices globally, with additional product portfolios in biosimilars, cholesterol-modifying and cardiovascular medicines, respiratory treatments, dermatology, bone health, and pain management. The company distributes a modest current dividend on a quarterly basis. The stock may appeal to income investors seeking exposure to the pharmaceutical sector, though the dividend yield is relatively low.

OGN key facts

Distribution Safety Score™
8 · High risk
Safety-Adjusted Yield
0.05%
Asset type
Stock
Asset class
Equity
Inception date
05/14/2021
Distribution rate
0.59%
Distribution frequency
Quarterly
Trailing yield
0.58%
Last close
$13.72
Market cap
$3,603,001,600
Average volume
2113300.0
Last dividend
$0.0200
Ex-dividend date
08/14/2026
Payment date
09/10/2026
Beta
1.52
Payout ratio
0.0254
P/E ratio
17.5897
Forward P/E
5.0891
EPS
$0.78